Department of Hepatology, The First Hospital of Jilin University, Changchun, China.
BMC Gastroenterol. 2023 Jan 30;23(1):26. doi: 10.1186/s12876-022-02632-z.
To investigate the usefulness of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), protein C (PC), and thromboelastography (TEG) to serve as a predictor of portal vein thrombosis (PVT) in patients with liver cirrhosis. Additionally, we examined the clinical significance of the above indicators in terms of disease progression.
A total of 123 patients with liver cirrhosis were recruited from May 2021 to December 2021, according to the imaging findings. They were divided into the PVT group (n = 52) and the non-PVT group (n = 71). Furthermore, patients with PVT were divided into plasma transfusion groups (n = 13) and non-plasma transfusion groups (n = 39). The basic general information, past medical history, laboratory, and imaging examination data were collected and analyzed.
In univariate analysis, there was no significant difference between the two groups in IL-6, PC, reaction time (R), alpha angle (Angle), maximum amplitude, or coagulation index (CI) (P > 0.05). TNF-α in the PVT group was significantly lower than that in the non-PVT group (P = 0.001). K-time (K) in the PVT group was significantly higher than that in the non-PVT group (P = 0.031). There was no significant difference in IL-6, TNF-α, PC, or TEG between different Child-Pugh classification groups (P > 0.05). There were no significant differences in TEG between the plasma transfusion group and the non-plasma transfusion group. In Binary logistic regression analysis, TNF-α (OR = 0.9881, 95%CI = 0.971, 0.990, P < 0.001), K(OR = 1.28, 95% = 1.053, 1.569, P = 0.014), activate partial thromboplastin time (APTT) (OR = 0.753, 95%CI = 0.656, 0.865, P < 0.001), portal vein diameter (OR = 1.310, 95%CI = 1.108, 1.549, P = 0.002)and the history of splenectomy or embolism (OR = 7.565, 95%CI = 1.514, 37.799, P = 0.014)were related to the formation of PVT.
TNF-α, K, APTT, portal vein diameter, and splenectomy or embolism history were associated with PVT formation, but IL-6 was not.
探讨白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、蛋白 C(PC)和血栓弹力图(TEG)在预测肝硬化患者门静脉血栓形成(PVT)中的作用,并分析这些指标在疾病进展方面的临床意义。
选取 2021 年 5 月至 2021 年 12 月根据影像学检查结果确诊的 123 例肝硬化患者为研究对象。根据影像学检查结果,将患者分为 PVT 组(n=52)和非 PVT 组(n=71)。进一步根据治疗方法将 PVT 组患者分为血浆输注组(n=13)和非血浆输注组(n=39)。收集并分析患者的基本一般资料、既往病史、实验室和影像学检查数据。
单因素分析结果显示,两组患者的 IL-6、PC、反应时间(R)、α角(Angle)、最大振幅和凝血指数(CI)比较,差异均无统计学意义(P>0.05);PVT 组患者的 TNF-α水平明显低于非 PVT 组(P=0.001)。PVT 组患者的 K 时间(K)明显长于非 PVT 组(P=0.031)。不同 Child-Pugh 分级组患者的 IL-6、TNF-α、PC 或 TEG 比较,差异均无统计学意义(P>0.05)。血浆输注组和非血浆输注组患者的 TEG 比较,差异无统计学意义。二元逻辑回归分析结果显示,TNF-α(OR=0.9881,95%CI=0.971,0.990,P<0.001)、K(OR=1.28,95%CI=1.053,1.569,P=0.014)、活化部分凝血活酶时间(APTT)(OR=0.753,95%CI=0.656,0.865,P<0.001)、门静脉直径(OR=1.310,95%CI=1.108,1.549,P=0.002)和脾切除术或栓塞史(OR=7.565,95%CI=1.514,37.799,P=0.014)与 PVT 的形成有关。
TNF-α、K、APTT、门静脉直径和脾切除术或栓塞史与 PVT 的形成有关,而 IL-6 与 PVT 的形成无关。